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BACKGROUND/PURPOSE: The etiology of pneumonia is usually unknown, but the availability of uri-
nary pneumococcal and Legionella antigen tests can improve the diagnostic yield. Our aim was to provide 
clinical clues to help clinicians perform the appropriate urinary antigen tests.
METHODS: A retrospective study of patients admitted to the National Cheng Kung University Hospital 
between July 2006 and June 2008 was conducted. Patients aged over 18 years presenting with clinical 
symptoms and signs, radiological findings compatible with pneumonia, and a positive pneumococcal 
or Legionella pneumophila urinary antigen test, were included. Medical records were reviewed for data 
collection.
RESULTS: Overall, 55 adults with pneumonia, including 42 with pneumococcal pneumonia (PP) and 
13 with Legionella pneumonia (LP), were enrolled. On admission, patients with PP tended to be older 
(73.5 years vs. 59.1 years; p = 0.001), had lower body weights (52.0 kg vs. 69.7 kg; p < 0.001), more frequent 
respiratory symptoms (59.5% vs. 0%; p < 0.001), and lower systolic (123.0 mmHg vs. 141.0 mmHg; p = 0.004) 
and diastolic blood pressures (68.3 mmHg vs. 81.7 mmHg; p = 0.008), compared with patients with LP. 
However, those with LP had higher body temperatures (39.0°C vs. 37.5°C; p < 0.001), a higher incidence of 
relative bradycardia (45.5% vs. 0%; p < 0.001), diarrhea (15.4% vs. 0%; p = 0.053), and lower platelet counts 
(178.5 × 103/mm3 vs. 233.7 × 103/mm3; p = 0.026). Radiological findings showed that the major abnormal-
ity, lobar consolidation, was indistinguishable between LP and PP. The percentage of patients requiring 
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intensive care (35.7% vs. 38.5%) or ventilator support (31% vs. 23.1%) and in-hospital crude mortality rates 
(9.5% vs. 7.7%) was similar in both groups.
CONCLUSION: Some clinical and laboratory characteristics may be regarded as important clues indicating 
the need for an appropriate urinary antigen test in patients with pneumonia.
KEYWORDS: Streptococcus pneumoniae, Legionella pneumophila, urinary antigen tests, differential diagnosis
patient with pneumonia may be not cost-effective. The 
present study is intended to provide clinical, laboratory or 
radiographic characteristics that distinguish pneumococcal 
pneumonia (PP) from Legionella pneumonia (LP), and to 
help clinicians to choose the appropriate UAT.
Methods
A retrospective study of patients admitted between 
July 2006 and June 2008 at the National Cheng Kung 
University Hospital, a medical center in Southern Taiwan, 
was conducted. Those aged over 18 years, presenting with 
symptoms and signs of lower respiratory tract infections, 
new infiltrations consistent with pneumonia on chest 
films, and positive urinary S. pneumoniae or L. pneumophila 
antigen tests (NOW, Binax, Scarborough, Maine, USA) 
were enrolled. For each patient, UAT for both pathogens 
were done. However, patients with recent S. pneumoniae or 
L. pneumophila infections in the month prior to admission, 
or hospitalized or followed up at the hospital for less than 
2 days, were excluded from the study. Medical records 
were reviewed for demographic information, underlying 
diseases, microbiological results, laboratory data, clinical 
course and outcome.
A patient was regarded as having HAP, if he had been 
hospitalized within the previous 10 days, or pneumonia 
developed at least 72 hours after admission.4 Otherwise, a 
patient was diagnosed as having CAP. A patient was con-
sidered to be a smoker if he smoked every day and had not 
tried to quit during the past 5 years, and an alcoholic if he 
consumed more than 80 g of alcohol per day,13 according to 
chart records. End stage renal disease (ESRD) was defined 
as an estimated creatinine clearance rate of < 15 mL/min/
1.73 m2, or receiving hemodialysis or peritoneal dialysis. 
Chronic obstructive pulmonary disease (COPD) and a 
Introduction
Streptococcus pneumoniae and Legionella pneumophila are 
among the most common pathogens causing pneumonia, 
whether it is community-acquired pneumonia (CAP) or 
hospital-acquired pneumonia (HAP). S. pneumoniae is re-
garded as the cause in about one-third of patients with 
CAP,1–3 and is an important cause of early-onset HAP 
with a definitive diagnosis.4
L. pneumophila is the leading cause of CAP in some 
countries,2 and hospital-acquired Legionella pneumonia 
has a fatality rate of up to 28%.5 Moreover, S. pneumoniae 
and Legionella are two major pathogens causing severe 
cases of CAP that require admission to intensive care 
units.1 Therefore, it is important to distinguish the clini-
cal characteristics and radiographic findings of pneumo-
nia caused by these two pathogens.6–8
In order to improve the etiological diagnosis of pneu-
monia, a non-invasive diagnostic tool, the detection of 
antigens in urine, had been developed and is widely uti-
lized.1,9 The use of urinary antigen tests (UAT) to diagnose 
S. pneumoniae or Legionella infections has a high sensitivity 
(94–100%), a high specificity (95–100%), and is time-saving.9 
However, the urinary Legionella antigen test can detect only 
L. pneumophila serogroup 1. Using both UAT in patients 
with pneumonia has increased the diagnostic yield from 
36.4% to 41.1% with non-concentrated urine samples, and 
to 49.5% with concentrated urine samples.1 In some studies, 
the UAT was thought to be able to provide rapid detection 
of S. pneumoniae or L. pneumophila infections.1,10,11 Thus in 
the Infectious Disease Society of America/American Tho-
racic Society guidelines, patients with severe CAP should 
have some etiological assays, including blood and sputum 
cultures, and UAT for S. pneumoniae or L. pneumophila.12 
However, the routine use of both types of UAT in every 
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previous history of pulmonary tuberculosis were grouped 
together as chronic pulmonary disease.
Relative bradycardia was defined as an increase in 
heart rate of less than 10 beats/min/1ºC increase in tem-
perature, with the pulse rate ranging from 38.9ºC to 
41.1ºC.14 Chest X-ray films were revealed by a pulmon-
ologist who was unaware of the UAT results. The radio-
logical findings were classified as lobar consolidation, 
interstitial infiltrations (reticular, reticulonodular, or 
nodular patterns), pleural effusions, pneumothorax, or 
increased infiltration without any the above described 
characteristics.
Statistical analysis was performed by using SPSS version 
12.0 (SPSS Inc., Chicago, IL, USA). Continuous data were 
presented as mean ± standard deviations. The χ2 test or 
Fisher’s exact test were used for comparing categorical 
variables, and the Student’s t test for continuous variables. 
A two-tailed p value of less than 0.05 was considered to be 
statistically significant. The logistic regression model was 
used to test the variables with p ≤ 0.1 in the χ2 test, Fisher’s 
exact test or Student’s t test.
Results
During the study period, 787 urinary samples underwent 
the Legionella antigen test and 429 the pneumococcal anti-
gen test. Thirteen (1.65%) of the urinary Legionella antigen 
tests and 122 (28.44%) of the pneumococcal antigen tests 
were positive. The 122 urine samples containing pneumo-
coccal antigens were obtained from 120 patients, 78 (65.0%) 
of whom were children. Therefore, 55 adults with pneu-
monia, including 42 adults with urinary pneumococcal 
antigen and pneumonia diagnosed as PP, and 13 with uri-
nary L. pneumophila serotype 1 antigen and pneumonia 
(LP), were included. Their demographic characteristics 
and underlying illnesses are shown in Table 1. Patients 
with PP were older (73.5 years vs. 59.1 years, p = 0.001) and 
had lower body weights (52.0 kg vs. 69.7 kg, p < 0.001) than 
patients with LP. No difference was noted in terms of gender 
or underlying conditions. PP was more often community-
acquired than LP (95.2% vs. 76.9%, p = 0.080), though this 
was not statically significant. LP tended to prevail in pa-
tients with alcoholism (15.4% vs. 4.8%, p = 0.234) and ESRD 
Table 1. Demographic characteristics and underlying illness of patients with pneumococcal and Legionella pneumoniaa
 Pneumococcal pneumonia (n = 42) Legionella pneumonia (n = 13) p
Mean age (yr) 73.5 ± 14.1 59.1 ± 11.5 0.001
Body weight (kg)  52.0 ± 11.4 69.7 ± 15.7 < 0.001
Sex, male 30 (71.4) 10 (76.9) 1.000
Community-acquired pneumonia 40 (95.2) 10 (76.9) 0.080
Underlying illness 31 (73.8) 8 (61.5) 0.489
 Hypertension 16 (38.1) 5 (38.5) 1.000
 Diabetes mellitus 12 (28.6) 4 (30.8) 1.000
 Chronic pulmonary disease 10 (23.8) 1 (7.7) 0.266
  Chronic obstructive pulmonary disease 6 (14.3) 1 (7.7) 1.000
  Previous pulmonary tuberculosis 6 (14.3) 0 (0) 0.317
 Malignancy 8 (19.0) 2 (15.4) 1.000
 Smoking 6 (14.3) 2 (15.4) 1.000
 Stroke 6 (14.3) 1 (7.7) 1.000
 Bed-ridden status 6 (14.3) 0 (0) 0.317
 Congestive heart failure 3 (7.1) 0 (0) 1.000
 Alcoholism 2 (4.8) 2 (15.4) 0.234
 End-stage renal disease 2 (4.8) 3 (23.1) 0.080
 Coronary artery disease 1 (2.4) 1 (7.7) 0.420
aData presented as mean ± standard deviations or n (%).
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(23.1% vs. 4.8%, p = 0.080), and PP in those with chronic 
pulmonary diseases (28.6% vs. 7.7%, p = 0.266).
The clinical symptoms and signs in patients with pneu-
monia are shown in Table 2. Patients with PP often had in-
creased sputum production (59.5% vs. 0%, p < 0.001), and 
those with LP were more likely to have diarrhea (15.4% vs. 0%, 
p = 0.053). As far as clinical signs were concerned, patients 
with LP had higher body temperatures (39.0°C vs. 37.5°C, 
p < 0.001), and were more likely to have relative bradycardia 
(45.5% vs. 0%, p < 0.001). In contrast, patients with PP had 
lower systolic (123.0 mmHg vs. 141.0 mmHg, p = 0.004) and 
diastolic (68.3 mmHg vs. 81.7 mmHg, p = 0.008) blood pres-
sures. Therefore, our logistic regression model included age, 
body weight and underlying diseases. Only lower body 
weight was independently associated with PP (adjusted odds 
ratio = 1.12; 95% confidence interval = 1.01–1.23; p = 0.024).
The laboratory and radiographic findings of the two 
groups are presented in Table 3. There was no significant 
difference between patients with LP and PP in terms of 
leukocyte counts, hemoglobin, serum aminotransferases, 
sodium, and creatinine levels. However, patients with LP 
had lower platelet counts (178.5 × 109/L vs. 233.7 × 109/L, 
Table 2. Clinical presentations of patients with pneumococcal and Legionella pneumonia
Characteristics Pneumococcal pneumonia (n = 42) Legionella pneumonia (n = 13) p
Symptoms
 Fever 35 (83.3) 13 (100) 0.179
 Cough 30 (71.4) 7 (53.8) 0.314
 Sputum production 25 (59.5) 0 (0) < 0.001
 Dyspnea 25 (59.5) 6 (46.2) 0.525
 Pleuritic chest pain 5 (11.9) 0 (0) 0.324
 GI discomfortb 5 (11.9) 3 (23.1) 0.376
 Chills 4 (9.5) 1 (7.7) 1.000
 Confusion 4 (9.5) 0 (0) 0.562
 Sore throat 2 (4.8) 1 (7.7) 0.562
 Headache 1 (2.4) 0 (0) 1.000
 Rhinorrhea 1 (2.3) 0 (0) 1.000
Signs
 Body temperature (°C) 37.5 ± 0.9 39.0 ± 0.7 < 0.001
 Pulse rate (/min) 102.9 ± 17.0 110.5 ± 13.9 0.183
 Relative bradycardia 0 (0) 5 (45.5) < 0.001
 Respiratory rate (/min) 23.1 ± 6.3 21.4 ± 2.2 0.156
 Systolic BP (mmHg) 123.0 ± 17.2 141.0 ± 18.1 0.004
 Diastolic BP (mmHg) 68.3 ± 14.5 81.7 ± 13.8 0.008
 Abnormal breathing sounds 37 (88.1) 9 (69.2) 0.192
 Crackles 32 (76.2) 7 (53.8) 0.165
 Decreased breathing sounds 6 (14.3) 0 (0) 0.317
 Wheezing 4 (9.5) 3 (23.1) 0.337
Clinical outcome
 Hospitalization (d) 12.2 ± 6.8 23.9 ± 21.0 0.071
 Fever (d) 3.4 ± 3.4 3.6 ± 2.1 0.224
 ICU stay  15 (35.7) 5 (38.5) 0.553
 Ventilator support 13 (31.0) 3 (23.1) 0.734
 Crude mortality rate 4 (9.5) 1 (7.7) 1.000
aData presented as mean ± standard deviations or n (%); bGI discomfort includes nausea, vomiting, diarrhea, and abdominal pain. GI = 
Gastrointestinal; BP = blood pressure; ICU = intensive care unit.
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p = 0.026). The major radiographic finding on chest films 
in patients with either PP or LP was lobar consolidation; 
found in 77.5% of patients with PP and 91.7% with LP. Chest 
films showing a typical lobar consolidation pattern are 
shown in the Figure. However, the degree of lobar consoli-
dation was indistinguishable between PP and LP.
When a clinical diagnosis of PP was established, 22 
(52.4%) patients were treated with β-lactam agents (mainly 
Table 3. Laboratory and radiographic findings of patients with pneumococcal and Legionella pneumoniaa
Characteristics Pneumococcal pneumonia (n = 42) Legionella pneumonia (n = 13) p
Laboratory findings
 White blood count (× 109/L) 14.0 ± 7.8 11.6 ± 2.9 0.108
  Neutrophils (%) 80.6 ± 16.3 83.8 ± 15.3 0.532
 Hemoglobin (g/dL) 13.8 ± 14.9 11.9 ± 2.4 0.644
 Platelet (× 109/L) 233.7 ± 111.9 178.5 ± 58.9 0.026
 C-reactive protein (mg/L) (n = 54) 182.9 ± 104.6 238.6 ± 174.5 0.311
 Creatine phosphokinase (U/L) (n = 19) 108.4 ± 108.3 301.7 ± 338.5 0.274
 Aspartate aminotransferase (U/L) 75.7 ± 101.7 67.2 ± 53.9 0.775
 Alanine aminotransferase (U/L) 48.7 ± 98.4 69.3 ± 77.2 0.492
 Serum sodium (mmol/L) 134.1 ± 9.2 136.1 ± 3.7 0.270
 Serum potassium (mmol/L) 3.9 ± 0.9 3.8 ± 0.7 0.584
 Creatinine (mg/dL) 1.5 ± 1.0 2.6 ± 2.8 0.214
Radiographic findingsb
 Lobar consolidation 31 (73.8) 11 (91.7) 0.420
 Interstitial infiltrations 14 (35.0) 1 (8.3) 0.143
  Reticulonodular pattern 10 (25.0) 1 (8.3) 0.421
  Reticular pattern 2 (5.0) 0 (0) 1.000
  Nodular pattern 2 (5.0) 0 (0) 1.000
 Pleural effusion 6 (15.0) 0 (0) 0.316
 Increased infiltration 2 (4.8) 1 (7.7) 0.562
 Pneumothorax 1 (2.5) 0 (0) 1.000
aData presented as mean ± standard deviation or n (%); bA patient may have more than one radiological finding on the chest film.
A B
Figure. Typical lobar consolidation in chest X-rays. (A) A 62-year-old female with diabetes mellitus and urinary pneumococcal antigen. 
(B) A 70-year-old male with chronic obstructive pulmonary disease and urinary Legionella antigen.
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amoxicillin/clavulanate or ampicillin/sulbactam), 18 (42.6%) 
with penicillin plus fluoroquinolone (moxifloxacin or 
levofloxacin), and two (4.8%) with fluoroquinolone. In con-
trast, antimicrobial therapy for LP was fluoroquinolone 
(moxifloxacin or levofloxacin) in nine patients (69.2%), 
a macrolide (azithromycin or roxithromycin) in one pa-
tient (7.7%), and sequential therapy in one patient (7.7%). 
Con cerning the clinical outcomes of the two groups, there 
was no difference in fever duration, or in the need for in-
tensive care unit care or ventilator support. Likewise, the 
crude mortality rate for patients with PP and LP were sim-
ilar (9.5% and 7.7%, respectively). However, patients with 
LP tended to have a longer period of hospitalization com-
pared with PP patients (23.9 days vs. 12.2 days, p = 0.071).
Discussion
Though 1.65% of Legionella UAT and 28.76% pneumococ-
cal UAT were positive, we did not perform UAT in every 
patient with pneumonia. These data should not be inter-
preted as representing the “incidence” of pneumonia. The 
present study shows that there are characteristic clinical 
and laboratory findings in patients with PP and LP, which 
may be helpful in distinguishing one form of the disease 
from the other. Patients with PP were often older and had 
a lower body weight. As for underlying diseases, LP tended 
to prevail in patients with alcoholism and ESRD, and PP in 
those with chronic pulmonary disease. It has been shown 
that CAP caused by S. pneumoniae is more often associated 
with patients that have underlying diseases, especially 
COPD and neoplasms, while CAP caused by L. pneumophila 
is more frequently seen in individuals with alcoholism.15 
However, another study concluded that CAP caused by 
L. pneumophila was often seen in male smokers with alco-
holism, but fewer underlying diseases.16 In some studies, 
L. pneumophila was more prevalent in older males with un-
derlying disease.17,18 In a German study, most hospitalized 
patients with LP were older men with underlying diseases, 
but outpatients were younger, had less co-morbidity, and 
no gender predominance19 Therefore, these clinical expe-
riences indicate that the diversity of host factors seen in 
patients with LP may be related to variable environmental 
exposure, or to variable degrees of susceptibility in differ-
ent populations. Using a logistic regression model, we 
noted that patients with PP had a lower body weight. 
Though the cause of this finding is not evident, it is likely 
that those with PP were older and had certain underlying 
diseases.
PP seen in the patients in this study was associated 
with typical airway symptoms such as dyspnea, pleuritic 
chest pain, cough, excess sputum, and typical physical 
findings such as crackles or decreased breath sounds. In 
contrast, LP was often associated with high fever and less 
sputum production. Similar results have been observed 
in other studies.15,16 Relative bradycardia is claimed to be 
an important characteristic of Legionella infection,14,20 and 
was present in 46% of our 13 patients. The incidence 
of neurological symptoms, such as headache and confu-
sion, were more often found in CAP cases caused by 
L. pneumophila,15,16 but altered consciousness was not 
noted in our LP patients. This may be related to the 
younger age, fewer underlying diseases, and fewer hemo-
dynamic changes in the LP patients.
Patients with pneumonia caused by L. pneumophila had 
more frequent thrombocytopenia, severe hyponatremia 
(serum sodium < 130 mmol/L), altered liver function and 
creatine phosphokinase elevation.15,16,21,22 The patients 
with positive L. pneumophila UATs in our study had lower 
platelet counts, higher serum alanine aminotransferase, 
C-reactive protein, and creatine phosphokinase, but these 
were not significant. Hyponatremia was not noted in the 
patients with a positive L. pneumophila UAT, but this may 
be due to the relatively small number of patients studied. 
The culture-positive rate was 14.3% in patients with a posi-
tive S. pneumoniae UAT. This implies that using culture 
method for the diagnosis of S. pneumoniae or L. pneumophila 
infections is not reliable. Although the patients with a 
positive S. pneumoniae UAT seemed to pres ent more fre-
quently with interstitial patterns and pleural effusion on 
chest X-ray, there was no significant difference between 
the two groups. This result is compatible with previous 
studies.6,7 Patients with LP generally had longer hospital 
stays. This may be attributed to the higher percentage of 
HAP in the LP group, which prolongs hospitalization.
There are several limitations to our study. The first is 
the relatively small number of patients. Some trends were 
noted in our study, but they were not statistically signifi-
cant. Second, we did not include patients with S. pneumoniae 
or L. pneumophila grown from originally sterile sites, or 
those with a negative or no UAT. Only one patient with 
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pneumococcal antigen in the urine had concurrent pneu-
mococcal bacteremia. According to a previous study con-
ducted in Northern Taiwan, Legionella urinary antigens were 
present in 10 of 317 (3.15%) patients with CAP requiring 
hospitalization.23 Since not all patients with pneumonia 
are tested using either of the UATs, our study did not aim 
to report the prevalence of PP or LP in our hospitalized 
patients. However, to our knowledge, there is no other study 
that directly compares pneumonia patients with positive 
S. pneumoniae or L. pneumophila UATs. The results of our 
study may provide valuable clues for determining whether 
to perform a UAT.
In conclusion, there are some distinctive clinical and 
laboratory characteristics in patients with pneumococcal 
pneumonia and Legionella pneumonia. These findings 
provide significant hints for clinicians in choosing the 
appropriate UAT.
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